Infectious Disease

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online…

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game…

Babies who don’t get their first round of vaccines on time at 2 months of age are much…

New flu strain emerging as a severe health threat Fox News senior medical analyst Dr. Marc Siegel joins…

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online…

WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of…

We are doctors who trained continents apart: one of us in Sweden (Peterson) and one in India (Pai).…

The immunological arms race between virus and vaccines may change in the future, at least for bird flu…

Study design and study population Since February 2024, an adult outpatient clinic at the Lazzaro Spallanzani National Institute…

While AI has been used to identify potential drug candidates from libraries of promising molecules, investigators now claim…

Thomas L. Holland, MD, MSc Methicillin-resistant Staphylococcus aureus (MRSA) continues to rank among the US Centers for Disease…

Kevin Ault, MD on ACIP Shared Decision-Making, Informed Consent, and Vaccine Policy Kevin A. Ault, MD, vice president…

Early Release – Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Prevalence and Immunoreactivity, 2024–2050 – Volume 32, Number 3—March 2026 – Emerging Infectious Diseases journal